Celldex Therapeutics (CLDX) Return on Invested Capital (2018 - 2021)

Celldex Therapeutics' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.0% for Q4 2021.

• In Q4 2021, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2021 stood at 0.0% (changed 0.0% YoY), while the FY2021 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.0% for Q4 2021 at Celldex Therapeutics, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2021 to a low of 0.01% in Q4 2018.
• Historically, Return on Invested Capital has averaged 0.0% across 3 years, with a median of 0.0% in 2020.
• Biggest YoY gain for Return on Invested Capital was 0 bps in 2021; the steepest drop was 0 bps in 2021.
• A 3-year view of Return on Invested Capital shows it stood at 0.01% in 2018, then surged by 76 bps to 0.0% in 2020, then surged by 88 bps to 0.0% in 2021.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2021), 0.0% (Q3 2021), and 0.0% (Q4 2020), per Business Quant data.